Oncorena has received FDA approval for its IND application to begin Phase I/II trials of ONC175 (orellanine) in patients with metastatic renal cell carcinoma who require dialysis.
Levee Medical receives FDA approval to initiate ARID II, a multicenter randomized controlled trial evaluating the Voro Urologic Scaffold for treating stress urinary incontinence after prostate surgery.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.